Authors:
KUHR T
BECHTER O
GELEY S
DIETRICH H
DIRNHOFER S
EISTERER W
URL M
HILBE W
LUKAS P
THALER J
Citation: T. Kuhr et al., AUTOLOGOUS TRANSPLANTATION OF INTERLEUKIN-2 GENE TRANSDUCED BONE-MARROW IN A PRECLINICAL MODEL, Experimental hematology, 26(8), 1998, pp. 326-326
Authors:
BECHTER O
EISTERER W
PALL G
HILBE W
KUHR T
THALER J
Citation: O. Bechter et al., TELOMERE LENGTH AND TELOMERASE ACTIVITY PREDICT SURVIVAL IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL), Experimental hematology, 26(8), 1998, pp. 389-389
Authors:
BECHTER OE
EISTERER W
PALL G
HILBE W
KUHR T
THALER J
Citation: Oe. Bechter et al., TELOMERE LENGTH AND TELOMERASE ACTIVITY PREDICT SURVIVAL IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Cancer research, 58(21), 1998, pp. 4918-4922
Authors:
KUHR T
BECHTER O
GELEY S
EISTERER W
HILBE W
THALER J
Citation: T. Kuhr et al., DETECTION AND QUANTITATION OF GENETICALLY MARKED RESIDUAL LEUKEMIA AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION - A PRECLINICAL MODEL FOR MINIMAL RESIDUAL DISEASE, Blood, 90(10), 1997, pp. 269-269
Citation: T. Kuhr et al., GENETICALLY-DETERMINED TARGET ORGAN SUSCEPTIBILITY IN THE PATHOGENESIS OF SPONTANEOUS AUTOIMMUNE-THYROIDITIS - ABERRANT EXPRESSION OF MHC-CLASS-II ANTIGENS AND THE POSSIBLE ROLE OF VIRUS, Journal of autoimmunity, 7(1), 1994, pp. 13-25
Citation: T. Kuhr et al., TRANSFER OF THE TNF-ALPHA GENE INTO HEMATOPOIETIC PROGENITOR CELLS ASA MODEL FOR SITE-SPECIFIC CYTOKINE DELIVERY AFTER MARROW TRANSPLANTATION, Experimental hematology, 22(8), 1994, pp. 818-818
Citation: T. Kuhr et al., TRANSFER OF THE TUMOR-NECROSIS-FACTOR-ALPHA GENE INTO HEMATOPOIETIC PROGENITOR CELLS AS A MODEL FOR SITE-SPECIFIC CYTOKINE DELIVERY AFTER MARROW TRANSPLANTATION, Blood, 84(9), 1994, pp. 2966-2970
Citation: T. Kuhr et al., TRANSFER OF THE TUMOR-NECROSIS-FACTOR-ALPHA GENE INTO HEMATOPOIETIC PROGENITOR CELLS AS A MODEL FOR SITE-SPECIFIC CYTOKINE DELIVERY AFTER MARROW TRANSPLANTATION, Blood, 84(9), 1994, pp. 2966-2970
Authors:
THALER J
GASTL G
FLUCKINGER T
NIEDERWIESER D
HUBER H
SEEWANN H
SILLY H
LANG A
ABBREDERIS C
GADNER H
FEREBERGER W
SCHILLER L
KOCK L
FRIDRIK M
DUBA C
FALK M
BERGER M
KUHR T
HUBER C
Citation: J. Thaler et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALFA-2C - RESPONSE RATE AND TOXICITY IN A PHASE-II MULTICENTER STUDY, Seminars in hematology, 30(3), 1993, pp. 17-19